Related Experiment Video
Updated: Aug 9, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
Single nucleotide polymorphism: a new risk factor for endometrial cancer?
Sokbom Kang1, Ju Won Roh, Jae Weon Kim
1Research Institute and Hospital, Center for Cervical Cancer, National Cancer Center, Goyang, Gyeonggi, 411-764, Korea.
Future Oncology (London, England)
|March 25, 2006
Summary
Identifying common genetic polymorphisms can help assess endometrial cancer risk. Research links gene variations in estrogen metabolism, p53 pathways, cell cycle regulation, and DNA repair to cancer development, paving the way for future genetic testing.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Endometrial cancer risk is influenced by genetic factors.
- Germline polymorphisms in key genes are being investigated for their association with cancer risk.
- Previous research focused on estrogen metabolism and p53 pathways.
Purpose of the Study:
- To identify common genetic polymorphisms associated with endometrial cancer risk.
- To explore the role of gene variations in hormone metabolism and anti-tumor activities.
- To assess the potential for future genetic testing for endometrial cancer risk.
Main Methods:
- Review of existing research on gene polymorphisms and endometrial cancer.
- Analysis of polymorphisms in estrogen receptor genes and related metabolic genes.
- Investigation of polymorphisms in the p53 gene and its downstream pathways.
- Study of polymorphisms in genes regulating cell cycle, proliferation, differentiation, and DNA repair.
Main Results:
- Common genetic polymorphisms can augment the effects of known risk factors for endometrial cancer.
- Genes involved in hormone metabolism and cellular anti-tumor activities are implicated.
- Polymorphisms in p53 pathway genes are correlated with endometrial cancer risk.
- Variations in genes controlling cell proliferation, differentiation, cell cycles, and DNA repair are studied.
Conclusions:
- Continuous identification of genetic polymorphisms is crucial for understanding endometrial cancer risk.
- Genetic variations in hormone metabolism and cellular anti-tumor pathways are significant.
- Accumulated data may enable genetic testing for endometrial cancer risk in the future.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...